文献速递甲状腺与颈部外科

4D-CT主导候选病灶大小与原发性甲状旁腺功能亢进四腺增生的关联

Association Between Size of Dominant Candidate Lesion on Four-Dimensional CT and Four-Gland Hyperplasia among Patients with Primary Hyperparathyroidism.
PubMed 文献 · J Am Coll Surg · 2022-04-20

该回顾性队列纳入2014至2020年间接受4D-CT定位及甲状旁腺切除术的原发性甲状旁腺功能亢进患者240例,其中四腺增生41例、单腺瘤155例、双腺瘤44例。校正BMI后,4D-CT上主导候选病灶最大径每增加1 mm,四腺增生风险降低约13%(OR 0.87,95%CI 0.78–0.96,p=0.009)。提示病灶较小与四腺增生风险升高相关,4D-CT定位或有助于鉴别四腺增生与腺瘤。

要点

  • 4D-CT主导候选病灶最大径每增1 mm,四腺增生风险降低约13%(OR 0.87)。
  • 四腺增生患者术前血钙高于正常上限1 mg/dL的比例低于腺瘤患者(63% vs 81%)。
  • 四腺增生患者报告症状的比例高于腺瘤患者(61% vs 43%)。

核心结论

  • 4D-CT上主导候选病灶较小与原发性甲状旁腺功能亢进患者四腺增生风险升高相关,4D-CT定位或可为鉴别四腺增生与腺瘤提供依据。

研究设计与样本

  • 回顾性分析2014至2020年前瞻性收集的机构数据库中接受4D-CT成像及甲状旁腺切除术的原发性甲状旁腺功能亢进患者。
  • 共纳入240例,按术中所见与病理分为四腺增生组41例与腺瘤组199例(单腺瘤155例、双腺瘤44例)。
  • 采用logistic回归模型评估4D-CT主导候选病灶最大径与四腺增生(对比单腺瘤和双腺瘤)的关联,并校正BMI。

主要发现

  • 四腺增生患者术前血钙高于正常上限1 mg/dL的比例低于腺瘤患者(63% vs 81%,p=0.02)。
  • 四腺增生患者报告症状的比例高于腺瘤患者(61% vs 43%,p=0.04)。
  • 校正BMI后,4D-CT主导候选病灶最大径每增加1 mm,四腺增生的比值降低约13%(OR 0.87,95%CI 0.78–0.96,p=0.009)。

临床怎么用

  • 对4D-CT显示主导候选病灶较小者,应警惕四腺增生可能,术前规划需考虑双侧探查而非仅行微创单侧切除。
  • 结合术前血钙升高幅度与症状报告情况综合评估四腺增生风险,辅助手术范围决策。

局限性

  • 为单中心回顾性分析,样本量240例,四腺增生组仅41例。
  • 仅评估4D-CT主导候选病灶最大径,未涉及其他影像特征或术者判断因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Four-dimensional (4D) CT localization allows minimally invasive parathyroidectomy as treatment for primary hyperparathyroidism (PHPT), but false positive localization is frequent. We sought to characterize the ability of 4D CT to predict four-gland hyperplasia (HP) based on the size of candidate lesions. STUDY DESIGN: We retrospectively analyzed patients with PHPT who underwent 4D CT imaging and parathyroidectomy between 2014 and 2020 from a prospectively collected institutional database. The cohort was stratified into two groups, HP vs single adenoma (SA) and double adenoma (DA), based on operative findings and pathology. Logistic regression models assessed the association between the greatest diameter of the dominant candidate lesion on 4D CT and the outcomes of four-gland hyperplasia vs SA and DA. RESULTS: Among a cohort of 240 patients, 41 were found to have HP, and 199 had adenomas (SA = 155, DA = 44). Patients with HP were less likely to have a preoperative calcium level greater than 1 mg/dL above the upper limit of normal compared with patients with adenomas (63% vs 81%, p = 0.02) and more likely to report symptoms (61% vs 43%, p = 0.04). After adjusting for BMI, we found an estimated 13% reduction in odds of HP for every 1-mm increase in the greatest diameter of dominant candidate lesions identified on 4D CT scan (odds ratio 0.87, 95% CI 0.78 to 0.96, p = 0.009). CONCLUSIONS: A smaller size of the dominant lesion on 4D CT scan is associated with an increased risk of HP in PHPT. Use of 4D CT imaging localization may provide evidence for differentiating HP from adenomas.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Broekhuis JM, Chaves N, Chen HW, et al. Association Between Size of Dominant Candidate Lesion on Four-Dimensional CT and Four-Gland Hyperplasia among Patients with Primary Hyperparathyroidism. J Am Coll Surg. 2022. PMID: 35839411. doi:10.1097/XCS.0000000000000240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。